CGC Stock: Canopy Growth Rallies After Earnings; Should You Buy Now?

CGC Stock: Canopy Growth Rallies After Earnings; Should You Buy Now?
BILL PETERS
·6 min read

Canopy Growth is surging as investors and executives bet on wider legalization in the U.S. while the company's profit outlook becomes clearer.

Continue reading

Recommended Stories

  • 3 Top 10 Robinhood Stocks You Can Buy and Hold

    You might need to sleep with one eye open if you own some of the most popular stocks on the Robinhood trading platform. The most popular stock of all on Robinhood is also one of the best long-term picks. Apple (NASDAQ: AAPL) ranks as the biggest publicly traded company based on market cap, but it's poised to grow even larger.

  • The company behind Louis Vuitton is now backing Birkenstock

    The German maker of what's affectionately deemed the original ugly sandal has a luxurious new owner.

  • India’s new social media guidelines could make Signal’s strength its weakness

    Using Signal is like "booking a ticket anonymously, boarding a bus and getting down, and the bus won't know who boarded."

  • Nasdaq finishes higher, tech stocks retrace some losses

    The tech-heavy Nasdaq index rallied in choppy trading on Friday, even as sentiment remained fragile after the index's worst performance in four months the day before as fears of rising inflation kept U.S. bond yields near a one-year high. The S&P 500 ended little changed, while the Dow index closed lower after earlier dropping to a three-week low. The Dow still posted gains of nearly 4% for the month, as investors bought into cyclical companies set to benefit from an economic reopening.

  • Third Stimulus Checks Are One Step Closer to Reality – How Much Will You Get?

    The House passed President Biden's $1.9 trillion stimulus package. While the bill faces hurdles in the Senate, the provisions authorizing another round of stimulus payments seem safe.

  • Less than half of Americans support student loan forgiveness: poll

    A new survey from Yahoo Finance and The Harris Poll finds 46% of Americans support some level of student loan forgiveness.

  • 'The first rule of a happy life,’ according to 97-year-old Charlie Munger

    “A happy life is very simple,” the 97-year-old Munger said during the Annual Meeting of Shareholders of the Daily Journal Corporation.

  • House Approves $3,000 Child Tax Credit for 2021

    The proposal would temporarily increase the child tax credit to $3,000 or $3,600 per child for most families and have 50% of it paid in advance by the IRS.

  • Your next stimulus check just cleared a big hurdle — what's the timing now?

    Here's what still has to happen, now that the U.S. House has given its OK.

  • Famous Las Vegas restaurant Lotus of Siam weathered COVID-19 with preparation, foresight

    Co-owner Penny Chutima and her mother, storied chef Saipin, saw what was happening in China and prepared early for the pandemic to hit the states.

  • Trump Organization Under Criminal Investigation in NY – Will Donald Trump’s Accountants Flip?

    Last night on MSNBC, Bloomberg reporter Tim O'Brien speculated that the lead accountant on the Trump Organization's taxes may turn state's evidence. Allen Weisselberg is the chief financial officer of...

  • Bank of America Issues Warning About Potential Stock Market Bubble

    As Bitcoin breaks the $50,000 mark and the Dow hovers in the low 30,000s, a new report from the Bank of America and EPFR Global reveals that the latest market exuberance "may precede a correction,"...

  • Warren Buffett: Bond investors world-wide 'face a bleak future'

    While Warren Buffett isn’t known to prognosticate on where interest rates are heading, he warns that fixed-income investors “face a bleak future."

  • Johnson & Johnson's Vaccine Gets Unanimous Backing Of FDA Panel, Emergency-Use Authorization Soon To Come

    Johnson & Johnson's (NYSE: JNJ) coronavirus vaccine candidate could be given clearance for emergency use today, following unanimous backing by a Food and Drug Administration panel. What Happened: The FDA plans to rapidly finalize the vaccine and authorize it for emergency use. It is working with other federal agencies to ensure timely vaccine distribution, Acting Commissioner Janet Woodcock said in a statement. The announcement followed a live-streamed one-day meeting on Friday of the FDA's Vaccines and Related Biological Products Advisory Committee. This vaccine is a single-dose shot for adults 18 years and older. An independent expert panel, consisting of 22 members, voted unanimously to authorize the vaccine candidate, deeming the benefits of the vaccine outweigh the known risks. Although committee members expressed apprehensions over lower efficacy in some adults over the age of 60, it was finally decided that this subgroup was too small a population to draw broader conclusions. "We believe our COVID-19 vaccine candidate has the potential to help change the trajectory of the pandemic and stand ready to make it available to protect the public as soon as possible," said Paul Stoffels, chief scientific officer at J&J. The recommendation was based on evidence provided by the company, including efficacy and safety data from the Phase 3 ENSEMBLE trial, which showed that the vaccine was 66% effective in preventing moderate-to-severe cases of the disease. Related Link: Why Merck Is Buying Autoimmune Disease Drug Company Pandion For $1.85B The overall efficacy, however, pales before the 95% efficacy reported by Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE)-BioNTech SE – ADR (NASDAQ: BNTX) for their vaccine candidates. Moderna and Pfizer-BioNTech received authorizations for their vaccine candidates in December. Unlike the messenger RNA vaccines of Moderna and Pfizer-BioNTech, J&J's vaccine candidate uses a single-dose regimen and is an experimental viral vector vaccine that uses a weakened form of adenovirus to transport genetic material to trigger immune response. J&J's vaccine candidate can remain stable for two years at -20 degrees Celsius, at least three months of which can be at temperatures of 2-8 degrees Celsius. The vaccines from Moderna and Pfizer, on the other hand, require cold-chain logistics to stay effective. What's Next: After emergency use authorization, the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices will provide a recommendation on the use and roll-out of J&J's vaccine. The company said it is prepared to supply its vaccine immediately upon authorization and expects to deliver enough single-dose vaccines by the end of March to vaccinate more than 20 million people in the U.S. The company plans to deliver 100 million single-dose vaccines in the U.S. during the first half of 2021. J&J also has an application pending before European regulators for obtaining conditional marketing authorization in the region. The World Health Organization is reviewing an emergency use listing for the vaccine. Related Link: The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida See more from BenzingaClick here for options trades from BenzingaThe Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For TricidaJohnson & Johnson's Single-Dose Coronavirus Shot Gets Favorable FDA Review Ahead Of Adcom Meeting© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • We Asked Successful Investors: Will You Be Adding Bitcoin to Your Portfolio?

    There's a recent mania taking over the investing world, and it's called cryptocurrency. Since the domain name Bitcoin.com was registered in 2008, the world has seen Bitcoin (CRYPTO: BTC) rise and fall, hitting just under $50,000 per token on Feb. 15, 2021. While many people are bullish on Bitcoin's prospects, many others feel it's just too risky for an average investor to hold in their portfolio.

  • Ford family puts personal station wagons up for sale at Barrett-Jackson auction

    The Ford family is auctioning a 1958 Edsel Bermuda Wagon and a 1947 Woody Wagon from its personal collection at Barrett-Jackson in Scottsdale, Ariz.

  • Buffett’s Berkshire Snaps Up Record $24.7 Billion of Own Stock

    (Bloomberg) -- Warren Buffett’s Berkshire Hathaway Inc. bought back a record $24.7 billion of its own stock last year and said there’s more to come, as the conglomerate struggled to find other ways to deploy its enormous pile of cash.The company’s purchase of $9 billion of shares in the fourth quarter matched a record set in the previous three-month period, Buffett said Saturday in his annual letter to investors.“Berkshire has repurchased more shares since year-end, and is likely to further reduce its share count in the future,” Buffett, 90, said in the letter. “That action increased your ownership in all of Berkshire’s businesses by 5.2% without requiring you to so much as touch your wallet.”Buffett’s letter, a closely-watched missive from one of the world’s most renowned investors, devoted large portions to the impact of repurchases, one of Berkshire’s biggest capital-deployment moves last year as it “made no sizable acquisitions.” He also shared his thoughts on the strategy of conglomerates, praising businesses such as Berkshire’s insurance operations and railroad.He shied away from some of the most controversial issues of the day, including politics, the pandemic and racial equality. But Buffett stood by his optimism for America, saying that progress on achieving a “more perfect union” was uneven but still moving forward.“Our unwavering conclusion: Never bet against America,” he said.There was a small amount of progress in paring the cash pile, which fell 5% in the fourth quarter to $138.3 billion. Buffett has struggled to keep pace with the flow in recent years as Berkshire threw off cash faster than he could find higher-returning assets to snap up.Apple Inc. is one of Berkshire’s top three most-valuable assets, at $120 billion, Buffett said. The technology company has said it intends to repurchase its own shares as well.“The math of repurchases grinds away slowly, but can be powerful over time,” Buffett said. “The process offers a simple way for investors to own an ever-expanding portion of exceptional businesses.”Separately, Buffett acknowledged that the $11 billion writedown Berkshire took last year was almost entirely due to what he conceded was a “mistake” in 2016, when he paid too much for Precision Castparts. Precision is a fine company, Buffett said, but he admitted he made a big error.“I was wrong, however, in judging the average amount of future earnings and, consequently, wrong in my calculation of the proper price to pay for the business,” Buffett said in the letter.Stock PortfolioSwings in Berkshire’s massive $281.2 billion stock portfolio feed into the company’s net income because of an accounting technicality. That drove the figure up 23% to $35.8 billion in the fourth quarter from a year earlier.Berkshire’s Class A shares gained roughly 2.4% last year, falling short of the 16% increase in the S&P 500.The billionaire only briefly touched on one of the largest questions looming over Berkshire -- how long he might stay at the helm. He once again referenced a favorite CEO, Mrs. Blumkin, who founded Nebraska Furniture Mart. She worked until she was 103 -- “a ridiculously premature retirement age as judged by Charlie and me,” Buffett wrote, referring to Charlie Munger, 97, a Berkshire vice chairman.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Griddy Barred From Texas Power Market for Payment Breach

    (Bloomberg) -- Griddy Energy LLC , a Texas retail electricity provider that came under fire after its customers received exorbitant power bills during the energy crisis last week, was barred from participating in the state’s power market Friday.The Electric Reliability Council of Texas revoked Griddy’s rights to conduct activity in the state’s electricity market due to nonpayment, according to a market notice seen by Bloomberg.The Macquarie Energy-backed company said previously it would challenge the prices set by the grid operator during the crisis and its chief executive officer, Michael Fallquist, declined to testify at Texas legislative hearings Friday.Griddy said in a statement Friday that the decision on pricing was made “to take the price out of the hands of the market,” adding that “we wanted to continue the fight for our members to get relief and that hasn’t changed.” For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Americans can’t file their income taxes fast enough — but they should brace for some unwelcome news in their 2020 refunds

    The IRS has received approximately 21% more individual returns than the agency received last year by Feb. 7, which was 12 days into the tax season last year.

  • After the coming third stimulus check, will you get a fourth?

    Congress is moving quickly on a bill to give you a third payment. Could there be another?